TEL AVIV, Israel — A single dose of intravenous vancomycin in eyes with gram-positive endophthalmitis results in erratic penetration, according to a study out of the Department of Ophthalmology at ...

Hospitalized children given high-dose intravenous infusions of the antibiotic vancomycin to treat drug-resistant bacterial infections face an increased risk for kidney damage -- an often reversible ...

Vancomycin (as HCl) 500mg/vial, 1g/vial; lyophilized pwd for IV infusion after reconstitution and dilution. Not for prophylaxis of endophthalmitis. Renal insufficiency. Monitor hearing, blood, renal ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Efficacy of once-weekly intravenous ...

Treating hospitalized children with the widely used combination antibiotic therapy of intravenous vancomycin hydrochloride and piperacillin-tazobactam (TZP) significantly increases their risk for ...

Back-to-back papers in the June 5th issue of New England Journal of Medicine reported positive phase 3 clinical trial results for two new intravenous antibiotics in the treatment of nasty bacterial ...

Patients with skin or skin structure infections may have two 2 new antibiotic options, both of which had similar efficacy and safety profiles as vancomycin in phase 3, randomized controlled trials ...

VANCOMYCIN is a penicillinase-resistant antibiotic that may be used in the treatment of staphylococcal infections. Because it is known to be excreted chiefly through the kidneys in normal persons 1 ...

LONDON, Dec. 8, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces the launch of the first-of-its-kind, ready-to-use vancomycin premix ...

Credit: Shutterstock. Intravenous (IV) antibiotics such as CPT is indicated for ABSSSIs "but real world clinical comparative data is limited." This article is written live from ID Week 2017 Annual ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Reviewed by Robert Jasmer, MD, Associate Clinical Professor of ...